Last Posted: Jun-07-2019 1PM
Last Posted: Jun 07, 2019
- Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer
K Nagpal et al, NPJ Digital Medicine, June 7, 2019 - ASCO Remembers Cancer Genetics Pioneer Dr. Henry T. Lynch
ACSO, June 4, 2019 - Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer.
Groot Vincent P et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 May - Development and validation of an immune-related gene pairs signature in colorectal cancer.
Wu Jianping et al. Oncoimmunology 2019 8(7) 1596715 - Effectiveness of a genetic test panel designed for gynecological cancer: an exploratory study.
Ida Koichi et al. Medical oncology (Northwood, London, England) 2019 May 36(7) 62 - Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.
Vocka Michal et al. Cancers 2019 May 11(6) - Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
Lin Chia-Yen et al. Urologic oncology 2019 May - Genome-wide cell-free DNA fragmentation in patients with cancer.
Cristiano Stephen et al. Nature 2019 May - Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
Liu Gao-Min et al. Cancer cell international 2019 19138 - Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Dieci Maria Vittoria et al. The oncologist 2019 May
.jpeg)
No hay comentarios:
Publicar un comentario